- Home
- GTBP vs LCFY Comparison
GTBP vs LCFY Comparison
Compare GTBP & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTBP
- LCFY
- Stock Information
- Founded
- GTBP 1965
- LCFY 2009
- Country
- GTBP United States
- LCFY Australia
- Employees
- GTBP N/A
- LCFY N/A
- Industry
- GTBP Biotechnology: Pharmaceutical Preparations
- LCFY
- Sector
- GTBP Health Care
- LCFY
- Exchange
- GTBP Nasdaq
- LCFY Nasdaq
- Market Cap
- GTBP 6.6M
- LCFY 7.3M
- IPO Year
- GTBP N/A
- LCFY 2022
- Fundamental
- Price
- GTBP $2.13
- LCFY $7.60
- Analyst Decision
- GTBP Strong Buy
- LCFY
- Analyst Count
- GTBP 1
- LCFY 0
- Target Price
- GTBP $11.00
- LCFY N/A
- AVG Volume (30 Days)
- GTBP 22.2K
- LCFY 31.0K
- Earning Date
- GTBP 11-14-2024
- LCFY 11-12-2024
- Dividend Yield
- GTBP N/A
- LCFY N/A
- EPS Growth
- GTBP N/A
- LCFY N/A
- EPS
- GTBP N/A
- LCFY N/A
- Revenue
- GTBP N/A
- LCFY $2,668,385.00
- Revenue This Year
- GTBP N/A
- LCFY N/A
- Revenue Next Year
- GTBP N/A
- LCFY N/A
- P/E Ratio
- GTBP N/A
- LCFY N/A
- Revenue Growth
- GTBP N/A
- LCFY N/A
- 52 Week Low
- GTBP $1.92
- LCFY $2.20
- 52 Week High
- GTBP $10.66
- LCFY $11.23
- Technical
- Relative Strength Index (RSI)
- GTBP 40.32
- LCFY 58.98
- Support Level
- GTBP $2.41
- LCFY $5.85
- Resistance Level
- GTBP $3.40
- LCFY $7.15
- Average True Range (ATR)
- GTBP 0.30
- LCFY 0.31
- MACD
- GTBP -0.04
- LCFY -0.01
- Stochastic Oscillator
- GTBP 6.09
- LCFY 76.36
About GTBP GT Biopharma Inc.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.